The Bt cotton saga
Rajeev Kumar, Partner, LexOrbis provides a commentary on the facts and questions of law that are raised in the current Bt. cotton…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Rooting out Rubella: Making it Mission Possible
The government needs to quash fears about safety of the rubella vaccine and establish its efficacy to achieve its goal of…
The Social Way to Success
India Pharma Inc needs to leverage the potential of social media to up its game in times to come
Era of Electroceuticals Coming soon?
Electroceuticals, hailed as the next frontier in medicine, is garnering considerable interest from medical researchers and…
All bluster and no lustre?
With little or no financial incentives in Union Budget 2017, the pharmaceutical industry remains deprived of a cure for its…
Resurrecting Brand AP
Visakhapatnam and Nellore to play pivotal roles in rebuilding Andhra Pradesh's reputation as a leading pharma hub By Prathiba Raju
A Helping Hand
The search for a sustainable, affordable and complaint access strategy is a tough task but the gains outweigh the pains By Viveka…
Trends in 2017
What will be the most dominant business trends in the pharmaceutical sector in the year ahead?
Increasing access to medicines via collaboration and digitisation
A Vaidheesh, VP, South Asia and MD, India, GlaxoSmithKline Pharmaceuticals, in an exclusive interaction with Prathiba Raju…
Where the mind is without fear…
TK Kanchana, Director-General, Organisation of Pharmaceutical Producers of India (OPPI) talks about the trends which are most…
A year of opportunities and challenges
Vikas Bhadoria, Senior Partner, Mc Kinsey and Vivek Arora, Associate Partner, Mc Kinsey, talk about how the global industry is at…
Business trends in 2017
Utkarsh Palnitkar, Partner, National Head – Infrastructure, Government & Healthcare and National Head – Life Sciences…
Dominant business trends in 2017
Ameesh Masurekar, Director, AIOCD Pharmasofttech AWACS, talks about the prevalence of online retail, therapeutic and regulatory…
Indian pharma landscape in 2017
Antal International takes a closer look at the business trends that could be game changers for India's growing pharmaceutical…
Pharma cos need to realign biz models
Pharma companies should focus on high-performing therapeutic area and geographic markets and they need to realign their business…
Fixed dose combination drugs – to be banned or not to be banned
Ajay Bhargava, Vanita Bhargava and Aseem Chaturvedi explain how the FDC ban notification has adversely affected the pharma…
Trends in global and Indian pharma industry
Uttam Jain, Director, Neon Laboratories, elaborates on how the pharma industry will register positive growth trends in the next…
Pharma cos brace up for a paradigm shift
With vast and quick change in culture and various global platforms, the industry is to witness a growing trend of digitisation in…
Outlook for global medicines through 2021
Growth in spending on medicines in major pharmerging markets has slowed from 2–10 percentage points over the past five years and…
Experts examine the strategies for a new VUCA WORLD
Featuring - Jawed Zia, Novartis India
- Mike Warmuth, Abbott
- Daara Patel, IDMA
- Dr Ajit Dangi, Danssen Consulting
- Utkarsh…